Glibornuride
![Glibornuride synthesis:[2] See also: U.S. Patent 3,770,761; eidem, U.S. Patent 3,654,357 (to Hoffmann-La Roche).](/Images/godic/202501/15/Glibornuride_synthesis.svg2545.png")
Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.
Gliburnide is an endo-endo derivative made from camphor-3-carboxamode by borohydride reduction (exo approach), followed by Hofmann rearrangement to carbamate, followed by displacement with sodium tosylamide.